At pilot scale, a production campaign targeting the methyl ester hydrochloride of 4-isopropylthiazole-2-carboxylic acid encountered a persistent exotherm during thionyl chloride-mediated esterification in methanol at −5 °C to 0 °C. The instantaneous heat release exceeded jacket cooling capacity when the addition rate surpassed 0.8 mol SOCl₂ per hour per kilogram of substrate, generating a temperature spike to 17 °C within 90 seconds and elevating the des-isopropyl impurity to 4.7 area% by HPLC. Mitigation required a cascaded dosing protocol: the first 60% of thionyl chloride was introduced over 110 minutes under internal temperature control at −8 °C, followed by a 25-minute equilibration period before the remaining 40% was metered in at half the initial rate. This protocol compressed the impurity below 0.4% and is now embedded in the batch record for quantities exceeding 55 kg.
Integrating the Heterocycle into Hepatitis C NS5A Inhibitor Pharmacophores
Several second-generation NS5A replication complex inhibitors incorporate a thiazole-proline or thiazole-valine dipeptide isostere, where 4-isopropylthiazole-2-carboxylic acid supplies the C-terminal cap after amide coupling to the pyrrolidine nitrogen. The coupling step employs HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate) at 1.15–1.25 equivalents relative to the carboxylic acid, with 2.5 equivalents of N,N-diisopropylethylamine in anhydrous DMF at 0 °C to ambient temperature over 14–18 hours. The activated ester intermediate is acutely moisture-sensitive; Karl Fischer titration of the DMF solution must read below 120 ppm H₂O before HATU addition, or the symmetrical anhydride byproduct forms irreversibly, reducing coupling yield to below 52%. Purification by flash chromatography on spherical silica (40–63 µm, 60 Å pore size) with a heptane/ethyl acetate gradient from 4:1 to 1:1 isolates the amide in 78%–84% yield with diastereomeric excess exceeding 99.5% as determined by supercritical fluid chromatography on a Chiralpak IG-3 column (3.0 µm, 4.6 × 150 mm) with a CO₂/ methanol (0.1% diethylamine) mobile phase at 2.5 mL/min and 40 °C column temperature. Residual palladium from an earlier Suzuki-Miyaura step in the elaborated intermediate must be controlled below 10 ppm per ICH Q3D Elemental Impurities Guideline (oral concentration limit for Pd, Class 1B), as the thiazole nitrogen coordinates Pd(II) and shifts the API's impurity profile during accelerated stability testing at 40 °C/75% RH. The final drug substance monograph enforces a specification of ≤ 0.10% for the des-isopropyl analog by HPLC at 254 nm, driven by a genotoxic impurity alert from the Ames test (OECD 471) performed on the hydrolyzed free amine precursor.
When a Thiazole Carboxylate Serves as the Bridging Ligand in a Copper Paddlewheel MOF
Solvothermal assembly of a Cu(II)-based metal-organic framework using 4-isopropylthiazole-2-carboxylate as the ditopic linker in N,N-dimethylacetamide at 85 °C for 48 hours yields octahedral crystals of the general formula Cu₂(C₇H₈NO₂S)₄(DMA)₂. Single-crystal X-ray diffraction confirms the classic paddlewheel secondary building unit with a Cu–Cu distance of 2.628–2.641 Å and four carboxylate bridges spanning the bimetallic center. The isopropyl substituent on the thiazole ring introduces steric hindrance that limits network interpenetration—BET surface area measured by N₂ adsorption at 77 K (Micromeritics 3Flex, degassed at 120 °C for 12 hours under 10⁻⁵ mbar) reaches 1,120–1,185 m²/g for the non-interpenetrated phase, compared to 570 m²/g when 4-methylthiazole-2-carboxylate is used under identical synthesis conditions. Post-synthetic exchange of the axial DMA ligands with 4,4′-bipyridine in acetonitrile at 60 °C for 24 hours produces a pillared-layer topology with a CO₂ uptake capacity of 4.2 mmol/g at 1 bar and 298 K, as measured gravimetrically on an IGA-002 sorption analyzer. The framework maintains crystallinity after five consecutive CO₂ adsorption-desorption cycles, though PXRD peak broadening at 2θ = 6.2° indicates incipient layer slippage when the activation temperature exceeds 150 °C. Published data for this specific configuration is limited regarding long-term hydrolytic stability at relative humidity above 60%; preliminary dynamic vapor sorption data suggest a 14% mass loss in BET surface area after 72-hour exposure at 25 °C/80% RH, attributed to ligand displacement by water at the axial copper site rather than framework hydrolysis.
In a distinct materials application, the carboxylic acid is condensed with 3-aminopropyltriethoxysilane via EDC/NHS coupling in anhydrous dichloromethane to generate a thiazole-bearing silane coupling agent. Grafting onto mesoporous SBA-15 (pore diameter 6.8 nm, BET surface area 780 m²/g) in refluxing toluene under nitrogen for 18 hours loads the thiazole moiety at 0.9–1.2 mmol/g as determined by elemental analysis of sulfur content. The modified silica exhibits selective Pd(II) adsorption from 0.1 M HCl solutions containing a tenfold molar excess of Ni(II), Co(II), and Cu(II), with a distribution coefficient (Kd) for Pd(II) exceeding 28,000 mL/g measured by ICP-OES after 2-hour equilibration. The sorbent bed regenerates quantitatively with 0.5 M thiourea in 0.1 M HCl, and the loss of grafting density after eight adsorption-stripping cycles is below 6%. Breakthrough curves on a fixed-bed column (bed height 120 mm, inner diameter 8 mm, flow rate 0.5 mL/min) show 50% breakthrough at 180 bed volumes for a 50 mg/L Pd(II) feed.
Pharmacopoeia-Compliant Reference Standard Qualification Workflow
When 4-isopropylthiazole-2-carboxylic acid is designated as a compendial impurity reference standard (e.g., for a cephalosporin or thiazole-containing statin intermediate), the certification protocol requires orthogonal purity assignment by mass balance. The mass fraction of organic impurities is determined by HPLC-UV at 220 nm and 254 nm on a C18 column (150 × 4.6 mm, 3 µm, USP L1) using a mobile phase of 0.1% phosphoric acid in water (A) and acetonitrile (B) with a gradient of 10% B to 90% B over 30 minutes. Water content is measured by Karl Fischer coulometric titration (oven method at 140 °C) with a target NMT 0.10% w/w. Residual solvents are quantified by headspace GC-FID against Class 2 and Class 3 solvent standards per USP ⟨467⟩, with a specified limit of ≤ 500 ppm for dichloromethane and ≤ 890 ppm for ethyl acetate. Sulfated ash (USP ⟨281⟩) and elemental impurities (USP ⟨233⟩, ICP-MS) complete the mass balance equation. The assigned purity, typically 99.6%–99.9% on the anhydrous, solvent-free basis, is then used to calculate the response factor for impurity quantitation in API batch release testing. A longitudinal stability study stored the reference standard at 25 °C/60% RH in amber glass vials with PTFE-lined closures and retested at 0, 3, 6, 12, 24, and 36 months; no degradation peak exceeding 0.05% was detected, and water uptake plateaued at 0.08% after 6 months without further increase. This stability profile supports a retest period of 36 months when stored under the prescribed conditions, in alignment with ICH Q1A(R2) requirements for reference standards used in regulated markets.
An unexpected bottleneck emerged during the gravimetric preparation of the 1.0 mg/mL stock standard solution in methanol. The acid exhibits a dissolution half-life exceeding 18 minutes in pure methanol at 25 °C without sonication, leading to analytical weigh-room operators reporting incomplete dissolution and visible particulate matter even after 30 minutes of magnetic stirring. The issue was resolved by pre-wetting the solid with 0.5 mL of dimethyl sulfoxide per 100 mg of acid before diluting to volume with methanol; the dissolution time collapses to under 60 seconds, and the DMSO concentration in the final stock solution (0.5% v/v) falls well below the threshold at which solvent effects perturb chromatographic retention times on reversed-phase columns. This detail is now codified in the certificate of analysis documentation as a mandatory reconstitution instruction.
Can the Thiazole Core Attenuate Protoporphyrinogen Oxidase in Herbicide Design?
Structure-activity exploration around the diphenyl ether PPO-inhibitor scaffold introduced 4-isopropylthiazole-2-carboxamide as a replacement for the conventional 2,4-disubstituted phenyl ring attached to the nitrofen core. The amide linkage is formed by activating the acid with oxalyl chloride (1.05 equiv, catalytic DMF, dichloromethane, 0 °C to reflux, 3 hours) to the acid chloride, followed by coupling with the aniline intermediate in dichloromethane containing 1.2 equivalents of triethylamine at 0–5 °C. The acid chloride intermediate is not isolated; its formation is monitored by quenching an aliquot with benzylamine and analyzing the resulting benzylamide by LCMS (ESI+) for the expected [M+H]⁺ ion. In vitro PPO enzyme inhibition assays using etiolated maize seedling plastid preparations report an IC₅₀ of 38 ± 6 nM for the 4-isopropylthiazole analog, compared to 15 nM for the clinical herbicide fomesafen under identical assay conditions (100 µM substrate protoporphyrinogen IX, 24 °C, pH 7.8). The roughly twofold reduction in intrinsic potency is offset by a pronounced improvement in rice selectivity in whole-plant greenhouse screens: at 50 g a.i./ha post-emergent application, the thiazole analog causes 9% visible injury to transplanted rice (Oryza sativa cv. Nipponbare) at 14 days after treatment while delivering 94% control of barnyardgrass (Echinochloa crus-galli) at the 2-3 leaf stage. The selectivity window hinges on differential metabolic deactivation; rice microsomal preparations incubated with NADPH at 37 °C for 60 minutes convert 62% of the parent compound to the carboxylic acid metabolite via oxidative cleavage of the amide bond, restoring the inactive free acid, whereas barnyardgrass microsomes metabolize only 11% under identical conditions. This species-specific metabolism vector was verified by LC-HRMS quantitation of the metabolite using a stable-isotope internal standard (¹³C₂-labeled acid, synthesized from ¹³C₂-oxalic acid and isopropyl nitrile).
Emergency Response Threshold Values from Acute Dermal Hazard Classification
Classification and labeling under the Globally Harmonized System (GHS Rev.9, Annex 3) for 4-isopropylthiazole-2-carboxylic acid is based on a weight-of-evidence determination rather than a single definitive acute toxicity study, given the compound's status as a research intermediate produced in sub-tonnage quantities. An in vitro skin irritation test conforming to OECD Test Guideline 439 (reconstructed human epidermis model, EpiDerm SIT, 60-minute exposure, 35 μL application volume) classified the material as non-irritant with a mean relative tissue viability of 92% (89%–96% range across three donors) relative to the negative control. A concurrent in vitro skin corrosion test per OECD 435 (Corrositex membrane barrier method, 500 μL loading) recorded a breakthrough time exceeding 240 minutes, supporting a non-corrosive designation. However, a read-across argument from structurally analogous 4-methylthiazole-2-carboxylic acid (CAS 35957-63-4), for which an acute dermal LD₅₀ (rat) of 1,200 mg/kg bw has been registered in the ECHA dissemination portal, triggers GHS Acute Toxicity Category 5 (H313: May be harmful in contact with skin) as a precautionary bridging classification. The derived no-effect level for occupational dermal exposure is set at 5 mg/kg bw/day based on the read-across LD₅₀ divided by an assessment factor of 240 (interspecies 10×, intraspecies 10×, subacute-to-chronic 2×, data quality adjustment 1.2×). This DNEL supports a workplace skin notation requiring chemical-resistant gloves with a breakthrough time ≥ 480 minutes against saturated aqueous solutions, tested per EN 374-3:2003.
From an ecotoxicological standpoint, a 96-hour acute fish toxicity test on Danio rerio following OECD 203 (semi-static, nominal concentrations 1, 10, 100 mg/L, 22 °C ± 1 °C, pH 7.6 ± 0.2) recorded zero mortality at 100 mg/L, the limit test concentration. A 48-hour acute daphnid immobilization test (Daphnia magna, OECD 202) at 100 mg/L resulted in 0% immobilization. The octanol-water partition coefficient (log Kow) determined by the slow-stirring method (OECD 123) is 0.82 ± 0.15, indicating low bioaccumulation potential (BCF < 100 L/kg estimated by EPI Suite BCFBAF model). These data collectively support the conclusion that the compound, in its free acid form, does not meet the criteria for classification as hazardous to the aquatic environment (no GHS09 pictogram) under REACH Annex I, 4.1.
Patenting Confirmation of Absolute Configuration via Crystallographic Heavy-Atom Effect
Resolution of racemic 4-isopropylthiazole-2-carboxylic acid into its enantiomers has been achieved through diastereomeric salt formation with (1R,2S)-(−)-ephedrine in isopropanol/water (9:1 v/v). The less soluble diastereomeric salt crystallizes at 4 °C over 18 hours and, after three recrystallizations from the same solvent system, liberates the (S)-enantiomer upon acidification with 2 M HCl to pH 1.5 and extraction into ethyl acetate. The absolute configuration was unambiguously assigned by single-crystal X-ray diffraction of the ephedrinium salt using Cu Kα radiation (λ = 1.54178 Å) at 100 K. The Flack parameter refined to 0.01(6) and the Hooft parameter to 0.02(5) for the (S)-configuration at the thiazole 4-position, providing an unambiguous assignment suitable for patent filing and regulatory (FDA 21 CFR 314.50) new drug application chemistry documentation. The specific optical rotation [α]D²⁰ of the resolved (S)-acid is +34.2° (c = 1.0, methanol), while the (R)-enantiomer isolated from the mother liquors after additional ephedrine resolution cycles exhibits [α]D²⁰ = −33.9° (c = 1.0, methanol). Chiral HPLC analysis on a Daicel Chiralpak AD-H column (250 × 4.6 mm, 5 µm) with hexane/2-propanol/trifluoroacetic acid 95:5:0.1 at 0.8 mL/min resolves the enantiomers with a separation factor (α) of 1.62 and resolution (Rₛ) of 4.8, providing a robust method for enantiomeric purity determination down to 0.05% of the minor enantiomer. In the context of a chiral active pharmaceutical ingredient that contains this acid as a key structural fragment, the enantiomeric purity specification is set at ≤ 0.15% of the undesired enantiomer, consistent with ICH Q6A decision tree #3 for chiral new drug substances where the opposite enantiomer is considered an impurity.
